Published online Oct 15, 2022. doi: 10.4251/wjgo.v14.i10.2085
Peer-review started: April 6, 2022
First decision: June 12, 2022
Revised: June 15, 2022
Accepted: September 13, 2022
Article in press: September 13, 2022
Published online: October 15, 2022
Processing time: 190 Days and 4.5 Hours
Correction to “Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis” (PMID: 34853645 PMCID: PMC8603463 DOI: 10.4251/wjgo.v13.i11.1709). In this article, the picture of Figure 6C was misused due to our carelessness while typesetting. We corrected this mistake, and replaced the incorrect image with the correct one.
Core Tip: Correction to “Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis.”
- Citation: Teng BW, Zhang KD, Yang YH, Guo ZY, Chen WW, Qiu ZJ. Correction to “Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis”. World J Gastrointest Oncol 2022; 14(10): 2085-2087
- URL: https://www.wjgnet.com/1948-5204/full/v14/i10/2085.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i10.2085
After confirming the figures in our manuscript, we were surprised to find a mistake in
Provenance and peer review: Unsolicited article; Externally peer reviewed.
Peer-review model: Single blind
Specialty type: Oncology
Country/Territory of origin: China
Peer-review report’s scientific quality classification
Grade A (Excellent): A
Grade B (Very good): B
Grade C (Good): C
Grade D (Fair): 0
Grade E (Poor): 0
P-Reviewer: Liu H, United States; Solimando AG, Italy; Trna J, Czech Republic S-Editor: Chen YL L-Editor: Filipodia P-Editor: Chen YL
1. | Teng BW, Zhang KD, Yang YH, Guo ZY, Chen WW, Qiu ZJ. Genome-wide CRISPR-Cas9 screening identifies that hypoxia-inducible factor-1a-induced CBX8 transcription promotes pancreatic cancer progression via IRS1/AKT axis. World J Gastrointest Oncol. 2021;13:1709-1724. [PubMed] [DOI] [Cited in This Article: ] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis (0)] |